Leveraging IP in Psychedelics and Cannabis

Watch insights from our Leveraging IP for Business Growth in Cannabis & Psychedelics discussion at the GCI Virtual Summit (June 2021) with Ronan Levy, Field Trip Health; Dr. Jeffrey Becker, Bexson Biomedical; and Dr. Robert Laprairie, University of Saskatchewan.

To meet, network and collaborate with global cannabis and psychedelic leaders, check out theĀ GCI Summit.

To explore additional psychedelic content, click here.

Previous articleNew York Cannabis Control Board Approves 58 More Cannabis Cultivators
Next articleProfessionally Cannabis Podcast – Niklas Kouparanis, Bloomwell Group